US Emergency Labs Dedicated to Manufacturing Treatments for Pandemics for the Government May be Called Upon Soon As Potential Treatments for Ebola Develop Three US research facilities that have been established to make vaccines and therapeutics in the event of a public health emergency have said that they will support the US government if it wishes to increase efforts towards …
The Unbelievable Impact of Vaccines: US edition
“With the exception of safe water, no other modality, not even antibiotics, has had such a major effect on mortality reduction,” declared the WHO and UNICEF report on The State of the World’s Vaccines and Immunization. Don’t believe it? Think again. Source: World Health Organisation
Top 4 Challenges for Vaccine Manufacturers
Recently we undertook the research for the 15th annual World Vaccine Congress, and so asked what the biggest challenges are for each segment of the market. When we spoke to vaccine manufacturers, these came up as the 4 biggest issues: 1) Adjuvants Adjuvants are often lauded as the way forward to make vaccines more effective, but given how new …
An Overwhelming Measles Outbreak In The US Suggests Vaccines Aren’t Getting Through
Despite measles being preventable, a recent spate means that the US has experienced the largest measles outbreak since 1994. 228 cases of measles were recorded between January 1st and May 23rd of this year – 48 of which resulted in hospitalisation. The Centers for Disease Control and Prevention (CDC) released a report detailing the 20-year inflated high, essentially condemning those who …
GHTC report warns against R&D cuts in US
Cuts to the R&D programmes in the United States (US) could have a devastating impact on a number of important healthcare initiatives, including the world's first malaria vaccine. The latest report produced by the Global Health Technologies Coalition (GHTC) states that "cutting funding for global health and R&D programs would barely make a dent in reducing the US federal deficit …